Biffa Plc (BIFF) News

Cipher Pharmaceuticals Proposes Adding Robert Tessarolo and Arthur Deboeck to Board of Directors

Cipher Pharmaceuticals Proposes Adding Robert Tessarolo and Arthur Deboeck to Board of Directors Canada NewsWire MISSISSAUGA, ON, April 12, 2017...

Cipher Pharmaceuticals Reports 2016 Q4 & Year-End Financial Results

Cipher Pharmaceuticals Reports 2016 Q4 & Year-End Financial Results Canada NewsWire MISSISSAUGA, ON, March 2, 2017 MISSISSAUGA, ON, March 2...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...

Confidential Treatment Order (ct Order)

Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ

Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ PR Newswire MISSISSAUGA, ON, Nov. 29, 2016 MISSISSAUGA, ON, Nov. 29...

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Amended Statement of Changes in Beneficial Ownership (4/a)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...

Amended Statement of Beneficial Ownership (sc 13d/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Cipher Pharmaceuticals Reports Q3 2016 Financial Results

Cipher Pharmaceuticals Reports Q3 2016 Financial Results Canada NewsWire MISSISSAUGA, ON, Nov. 11, 2016 MISSISSAUGA, ON, Nov. 11, 2016 /CNW/...

Cipher Pharmaceuticals Announces Management Change

Cipher Pharmaceuticals Announces Management Change Canada NewsWire MISSISSAUGA, ON, Nov. 11, 2016 MISSISSAUGA, ON, Nov. 11, 2016 /CNW/ - Cipher...

Amended Statement of Ownership: Private Transaction (sc 13e3/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...